Twist Bioscience (TWST) Current Assets (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Current Assets data on file, last reported at $323.4 million in Q1 2026.

• Current Assets for Q1 2026 came in at $323.4 million, down 4.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $323.4 million (down 4.43% YoY), and the FY2025 annual result was $333.0 million, down 3.98% from the prior year.
• Current Assets rose to $323.4 million in Q1 2026 per TWST's latest filing, from $303.9 million in the prior quarter.
• Over five years, Current Assets peaked at $664.4 million in Q1 2022 and troughed at $303.9 million in Q4 2025.
• A 5-year average of $425.9 million and a median of $371.9 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2023: Current Assets surged 40.74% in 2022, then slipped 28.87% in 2023.
• A 5-year view of Current Assets shows it stood at $541.9 million in 2022, then decreased by 27.98% to $390.2 million in 2023, then dropped by 11.51% to $345.3 million in 2024, then dropped by 12.0% to $303.9 million in 2025, then gained by 6.44% to $323.4 million in 2026.
• Business Quant data shows TWST's Current Assets at $323.4 million in Q1 2026, $303.9 million in Q4 2025, and $333.0 million in Q3 2025.